Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Incyte Corp
(NQ:
INCY
)
66.91
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
66.91
Bid (Size)
64.09 (1)
Ask (Size)
67.00 (1)
Prev. Close
66.91
Today's Range
66.91 - 66.91
52wk Range
50.27 - 67.36
Shares Outstanding
222,430,635
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Looking for growth without the hefty price tag? Consider NASDAQ:INCY.
July 22, 2024
INCYTE CORP (NASDAQ:INCY) is showing decent growth, but is still valued reasonably.
Via
Chartmill
NASDAQ:INCY is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
July 10, 2024
INCYTE CORP (NASDAQ:INCY), an undervalued stock with good fundamentals.
Via
Chartmill
Performance
YTD
+2.23%
+2.23%
1 Month
+4.96%
+4.96%
3 Month
+29.32%
+29.32%
6 Month
+9.98%
+9.98%
1 Year
+4.89%
+4.89%
More News
Read More
S&P 500 Hits Record Highs, Eyes 6th Straight Gain As Powell Keeps Bears At Bay; Tesla Targets 10th Consecutive Win, Bank Stocks Rally: What's Driving Markets Tuesday?
July 09, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Incyte to Report Second Quarter Financial Results
July 09, 2024
From
Incyte
Via
Business Wire
NASDAQ:INCY is not too expensive for the growth it is showing.
July 01, 2024
Via
Chartmill
Analyst Expectations For Incyte's Future
June 18, 2024
Via
Benzinga
Despite its growth, NASDAQ:INCY remains within the realm of affordability.
June 10, 2024
Via
Chartmill
The 3 Most Undervalued Cathie Wood Stocks to Buy in July 2024
July 09, 2024
Via
InvestorPlace
7 Cheap Biotech Stocks With Major Upside Potential
July 09, 2024
Via
InvestorPlace
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 08, 2024
From
Incyte
Via
Business Wire
3 Highly Rated Biotech Stocks for Your July Buy List
July 05, 2024
Via
InvestorPlace
9 Analysts Have This To Say About Incyte
May 23, 2024
Via
Benzinga
This CrowdStrike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
July 02, 2024
Via
Benzinga
Stocks Chop As Wall Street Unpacks Powell Comments
July 02, 2024
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
July 01, 2024
Via
InvestorPlace
For those who appreciate value investing, NASDAQ:INCY is a compelling option with its solid fundamentals.
June 19, 2024
Via
Chartmill
Nasdaq 100, S&P 500 Close At Record Highs As Tech Stocks Reclaim Dominance: Thursday's Gainers & Losers
June 13, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Incyte Announces Final Results of Tender Offer
June 13, 2024
From
Incyte Corporation
Via
Business Wire
Incyte Announces Preliminary Results of Tender Offer
June 11, 2024
From
Incyte Corporation
Via
Business Wire
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2024
From
Incyte
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
June 04, 2024
Via
Benzinga
Incyte Completes Acquisition of Escient Pharmaceuticals
May 30, 2024
From
Incyte
Via
Business Wire
When you look at NASDAQ:INCY, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
May 29, 2024
Via
Chartmill
Hedge Funds Tweak Portfolios In Q1: Marvell, TD Synnex, AES Get More Love As Focus Shifts To AI
May 24, 2024
Via
Benzinga
Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings
May 21, 2024
From
Incyte
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.